50 related articles for article (PubMed ID: 30347270)
1. Optimized Digital Droplet PCR for BCR-ABL.
Maier J; Lange T; Cross M; Wildenberger K; Niederwieser D; Franke GN
J Mol Diagn; 2019 Jan; 21(1):27-37. PubMed ID: 30347270
[TBL] [Abstract][Full Text] [Related]
2. Analytical validation of the DropXpert S6 system for diagnosis of chronic myelocytic leukemia.
Wei W; Li S; Zhang Y; Deng S; He Q; Zhao X; Xu Y; Yu L; Ye J; Zhao W; Jiang Z
Lab Chip; 2024 Jun; 24(12):3080-3092. PubMed ID: 38747247
[TBL] [Abstract][Full Text] [Related]
3. Inter-laboratory comparison of chronic myeloid leukemia minimal residual disease monitoring: summary and recommendations.
Zhang T; Grenier S; Nwachukwu B; Wei C; Lipton JH; Kamel-Reid S;
J Mol Diagn; 2007 Sep; 9(4):421-30. PubMed ID: 17690211
[TBL] [Abstract][Full Text] [Related]
4. BCR-ABL testing in the evaluation of neutrophilia.
Smith CJ; Ruan GJ; Kluck LA; Maberry M; Go RS
Am J Hematol; 2024 May; ():. PubMed ID: 38760992
[No Abstract] [Full Text] [Related]
5. Performance Evaluation of the QXDx BCR-ABL %IS Droplet Digital PCR Assay.
Chung HJ; Hur M; Yoon S; Hwang K; Lim HS; Kim H; Moon HW; Yun YM
Ann Lab Med; 2020 Jan; 40(1):72-75. PubMed ID: 31432643
[TBL] [Abstract][Full Text] [Related]
6. Usage of Droplet Digital PCR (ddPCR) Assays for T Cell Quantification in Cancer.
Zoutman WH; Nell RJ; van der Velden PA
Methods Mol Biol; 2019; 1884():1-14. PubMed ID: 30465192
[TBL] [Abstract][Full Text] [Related]
7. Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy.
Vidal-Folch N; Gavrilov D; Raymond K; Rinaldo P; Tortorelli S; Matern D; Oglesbee D
Clin Chem; 2018 Dec; 64(12):1753-1761. PubMed ID: 30352867
[TBL] [Abstract][Full Text] [Related]
8. Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical
Petiti J; Lo Iacono M; Dragani M; Pironi L; Fantino C; Rapanotti MC; Quarantelli F; Izzo B; Divona M; Rege-Cambrin G; Saglio G; Gottardi EM; Cilloni D; Fava C
J Clin Med; 2020 May; 9(5):. PubMed ID: 32414125
[No Abstract] [Full Text] [Related]
9. Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients.
Alteri C; Cento V; Antonello M; Colagrossi L; Merli M; Ughi N; Renica S; Matarazzo E; Di Ruscio F; Tartaglione L; Colombo J; Grimaldi C; Carta S; Nava A; Costabile V; Baiguera C; Campisi D; Fanti D; Vismara C; Fumagalli R; Scaglione F; Epis OM; Puoti M; Perno CF
PLoS One; 2020; 15(9):e0236311. PubMed ID: 32898153
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid Leukemia.
Franke GN; Maier J; Wildenberger K; Cross M; Giles FJ; Müller MC; Hochhaus A; Niederwieser D; Lange T
J Mol Diagn; 2020 Jan; 22(1):81-89. PubMed ID: 31669230
[TBL] [Abstract][Full Text] [Related]
11. Exploration of treatment-free remission in CML, based on molecular monitoring.
Zhang Z; Zhou X; Zhou X; Cheng Z; Hu Y
Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38133525
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsies and minimal residual disease in lymphoid malignancies.
Bou Zerdan M; Kassab J; Saba L; Haroun E; Bou Zerdan M; Allam S; Nasr L; Macaron W; Mammadli M; Abou Moussa S; Chaulagain CP
Front Oncol; 2023; 13():1173701. PubMed ID: 37228488
[TBL] [Abstract][Full Text] [Related]
13. Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia.
Shelton DN; Bhagavatula P; Sepulveda N; Beppu L; Gandhi S; Qin D; Hauenstein S; Radich J
PLoS One; 2022; 17(3):e0265278. PubMed ID: 35298544
[TBL] [Abstract][Full Text] [Related]
14. Discontinuation of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: a Review of the Biological Factors Associated with Treatment-Free Remission.
Stuckey R; López Rodríguez JF; Gómez-Casares MT
Curr Oncol Rep; 2022 Apr; 24(4):415-426. PubMed ID: 35141859
[TBL] [Abstract][Full Text] [Related]
15. Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia.
Kövy P; Őrfi Z; Bors A; Kozma A; Gopcsa L; Dolgos J; Lovas N; Harasztdombi J; Lakatos V; Király Á; Mikala G; Vályi-Nagy I; Reményi P; Andrikovics H
PLoS One; 2021; 16(6):e0253386. PubMed ID: 34153064
[TBL] [Abstract][Full Text] [Related]
16. Clinical Utility of Droplet Digital PCR to Monitor BCR-ABL1 Transcripts of Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Post-chimeric Antigen Receptor19/22 T-Cell Cocktail Therapy.
Guan Y; Zhang M; Zhang W; Wang J; Shen K; Zhang K; Yang L; Huang L; Wang N; Xiao M; Zhou J
Front Oncol; 2021; 11():646499. PubMed ID: 33898316
[TBL] [Abstract][Full Text] [Related]
17. Consensus Recommendations for MRD Testing in Adult B-Cell Acute Lymphoblastic Leukemia in Ontario.
Tierens A; Stockley TL; Campbell C; Fulcher J; Leber B; McCready E; Sabatini PJB; Sadikovic B; Schuh AC
Curr Oncol; 2021 Mar; 28(2):1376-1387. PubMed ID: 33808300
[TBL] [Abstract][Full Text] [Related]
18. Digital PCR can provide improved
Smitalova D; Dvorakova D; Racil Z; Romzova M
Pract Lab Med; 2021 May; 25():e00210. PubMed ID: 33778144
[No Abstract] [Full Text] [Related]
19. Molecular Testing in CML between Old and New Methods: Are We at a Turning Point?
Soverini S; Bernardi S; Galimberti S
J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33261150
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
